Clinical trial
PROCRIT and Short-Term Outcomes in Orthopedic Surgery
NCT00236405 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Terminated
Key facts
| NCT number | NCT00236405 |
|---|---|
| Title | PROCRIT and Short-Term Outcomes in Orthopedic Surgery |
| Official title | A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Effects of of PROCRIT (Epoetin Alfa) on Short-Term Outcomes in Orthopedic Subjects Undergoing Primary Unilateral Knee Arthroplasty |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Collaborators | Ortho Biotech Products, L.P. Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia, Surgery, Arthroscopy |
| Intervention type | Drug |
| Interventions | epoetin alfa |
| Enrollment | 6 |
| Start date | Mar 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Oct 12, 2005 |
| Last update posted | Jun 10, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: